IBS vs Hyperliquid

Hyperliquid (HYPE) is 7283.3× the size of IBS (IBS) by market capitalisation. Over the past 30 days, IBS is ahead by 5.9 percentage points (IBS -0.2% against HYPE -6.0%). Their daily returns move loosely together (correlation 0.58 across 23 shared trading days). HYPE has been the more volatile of the two, at 82% annualised against IBS's 6%.

Correlation: 0.58
Size ratio: 1 : 7283.3
Ahead over 30 days: IBS

IBSIBS

$0.000684

24h: -0.28%
Market cap: $2.75M
Volume 24h: $55,927
Volatility (ann.): 6%

HyperliquidHYPE

$83.9400

24h: -1.98%
Market cap: $20.06B
Volume 24h: $1.46B
Volatility (ann.): 82%

IBS 0.0%Share of the two combined market caps100.0% HYPE

Performance

IBSHYPE

7 days-1.47%+4.65%HYPE
30 days-0.16%-6.04%IBS

Correlation

0.58over 23 shared trading days

−1 opposite0 unrelated+1 in step

7d: insufficient data30d: insufficient data90d: insufficient data1y: insufficient data

Measured on daily returns rather than on prices. Two assets that both simply trend upward score near 1.0 on raw prices whether or not they move together, so returns are what answer the question people mean by correlation.

Risk & extremes

Metric	IBS	HYPE
Max drawdown (400d)	-2.1%	-18.9%
Risk-adjusted return (90d)	-0.03	0.58

Relative strength over 90 days: HYPE outperformed IBS by 4.1% — measured on the IBS/HYPE ratio, so it holds regardless of market direction.

IBS →Hyperliquid →